Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
R. Sperling
Based on 9 articles published since 2010
(Why 9 articles?)
||||
Expertise Level
The expertise of R. Sperling ranks in the
  • Top 6.8%
  • ... of 133,018 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 9 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2016
  • Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · University of Southern California, Los Angeles, CA, USA. · Eli Lilly, Indianapolis, IN, USA. · Pintail Solutions, Indianapolis, IN, USA. · Baylor College of Medicine, Alzheimer's Disease and Memory Disorder Center, Baylor, TX, USA. · Global Alzheimer's Platform Foundation, USA. · University of British Columbia, Vancouver, BC, USA. · FaegreBD Consulting, Washington, DC, USA. · Johnson & Johnson, New Brunswick, NJ, USA. · Brown University, Providence, RI, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 28459045
2015
  • UMR1027 Inserm, F-31073, Toulouse, France ; University of Toulouse III, F-31073, France ; Gerontopole Toulouse, Toulouse University Hospital, F-31000, Toulouse, France. · Washington University School of Medicine, St. Louis, MO, USA. · University of Gothenburg, MöIndal Hospital, Sahlgrenska University Hospital, 43180 MöIndal, Sweden. · University Hospitals and University of Geneva, Geneva, Switzerland ; IRCCS Fatebenefratelli, Brescia, Italy. · Massachusetts General Hospital, Harvard Medical School, Boston, MA USA. · Division of Neuropharmacological Drug Products, U.S. Food and Drug Administration, USA. · Banner Alzheimer's Institute, Phoenix, AZ, USA. · The University of Alabama at Birmingham, Birmingham, AL, USA. · Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · The Warren Alpert Medical School of Brown University, Providence, RI, USA. · Baylor College of Medicine, Houston, TX, USA. · Department of Neurosciences, University of California, San Diego, San Diego, CA USA. · Pubmed 26247004
2014
  • Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Institut du Cerveau et de la Moelle épinière (ICM), UMR S 1127, Hôpital de la Pitié-Salpétrière Paris & CATI multicenter neuroimaging platform, France; Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio Fatebenefratelli Brescia, Italy. · AXA Research Fund & UPMC Chair; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Inserm U1127 Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière Paris, France. · The Campaign to Prevent Alzheimer's Disease by 2020 (PAD2020), Potomac, MD, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Inserm, U744, Lille, 59000, France; Université Lille 2, Lille, 59000, France; Institut Pasteur de Lille, Lille, 59000, France; Centre Hospitalier Régional Universitaire de Lille, Lille, 59000, France. · Institute of Brain, Behaviour and Mental Health, University of Manchester, UK. · Department of Radiology, Mayo Clinic, Rochester, MN, USA. · Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, 888 West Bonneville Avenue, Las Vegas, Nevada 89106, USA. · Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Internal Medicine, Institute for Aging & Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, TX, USA. · IRCCS Istituto Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; University Hospitals and University of Geneva, Geneva, Switzerland. · Executive Editor, Alzheimer's & Dementia. · Karolinska Institutet Alzheimer Research Center, NVS, Stockholm, Sweden. · Department of Psychiatry, University of Pittsburgh School of Medicine, USA; Department of Neurology, University of Pittsburgh School of Medicine, USA. · Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany. · Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France; Public health department, CHU de Toulouse. · Natbrainlab, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, King's College London, London, UK; Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (ICM), UMRS 1127 Paris, France; Inserm, U 1127, Paris, France; CNRS, UMR 7225, Paris, France. · CEA UNATI, Neurospin, CEA Gif-sur-Yvette, France & CATI multicenter neuroimaging platform. · Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. · Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Psychosomatic Medicine, University of Rostock, and DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany. · Department of Nuclear Medicine, University Hospital of Cologne, Cologne Germany. · Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland. · Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France. · Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpétrière University Hospital, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France. · Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, UK. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Inserm U1127 Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière Paris, France. · Inserm UMR1027, University of Toulouse, Toulouse, France. · Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Pubmed 26478889
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by R. Sperling in 2010-2020 about Alzheimer Disease:

  • Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force. 2019
  • What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force. 2018
  • EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials. 2017
  • Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. 2016
  • Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network. 2016
  • Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force. 2015
  • The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. 2014
  • MR imaging features of amyloid-related imaging abnormalities. 2013
  • A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. 2011
Show List of Full Article Records
Google Searches

Learn more about R. Sperling using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2016
  • Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · University of Southern California, Los Angeles, CA, USA. · Eli Lilly, Indianapolis, IN, USA. · Pintail Solutions, Indianapolis, IN, USA. · Baylor College of Medicine, Alzheimer's Disease and Memory Disorder Center, Baylor, TX, USA. · Global Alzheimer's Platform Foundation, USA. · University of British Columbia, Vancouver, BC, USA. · FaegreBD Consulting, Washington, DC, USA. · Johnson & Johnson, New Brunswick, NJ, USA. · Brown University, Providence, RI, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 28459045
2015
  • UMR1027 Inserm, F-31073, Toulouse, France ; University of Toulouse III, F-31073, France ; Gerontopole Toulouse, Toulouse University Hospital, F-31000, Toulouse, France. · Washington University School of Medicine, St. Louis, MO, USA. · University of Gothenburg, MöIndal Hospital, Sahlgrenska University Hospital, 43180 MöIndal, Sweden. · University Hospitals and University of Geneva, Geneva, Switzerland ; IRCCS Fatebenefratelli, Brescia, Italy. · Massachusetts General Hospital, Harvard Medical School, Boston, MA USA. · Division of Neuropharmacological Drug Products, U.S. Food and Drug Administration, USA. · Banner Alzheimer's Institute, Phoenix, AZ, USA. · The University of Alabama at Birmingham, Birmingham, AL, USA. · Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · The Warren Alpert Medical School of Brown University, Providence, RI, USA. · Baylor College of Medicine, Houston, TX, USA. · Department of Neurosciences, University of California, San Diego, San Diego, CA USA. · Pubmed 26247004
2014
  • Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Institut du Cerveau et de la Moelle épinière (ICM), UMR S 1127, Hôpital de la Pitié-Salpétrière Paris & CATI multicenter neuroimaging platform, France; Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio Fatebenefratelli Brescia, Italy. · AXA Research Fund & UPMC Chair; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Inserm U1127 Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière Paris, France. · The Campaign to Prevent Alzheimer's Disease by 2020 (PAD2020), Potomac, MD, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Inserm, U744, Lille, 59000, France; Université Lille 2, Lille, 59000, France; Institut Pasteur de Lille, Lille, 59000, France; Centre Hospitalier Régional Universitaire de Lille, Lille, 59000, France. · Institute of Brain, Behaviour and Mental Health, University of Manchester, UK. · Department of Radiology, Mayo Clinic, Rochester, MN, USA. · Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, 888 West Bonneville Avenue, Las Vegas, Nevada 89106, USA. · Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Internal Medicine, Institute for Aging & Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, TX, USA. · IRCCS Istituto Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; University Hospitals and University of Geneva, Geneva, Switzerland. · Executive Editor, Alzheimer's & Dementia. · Karolinska Institutet Alzheimer Research Center, NVS, Stockholm, Sweden. · Department of Psychiatry, University of Pittsburgh School of Medicine, USA; Department of Neurology, University of Pittsburgh School of Medicine, USA. · Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany. · Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France; Public health department, CHU de Toulouse. · Natbrainlab, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, King's College London, London, UK; Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (ICM), UMRS 1127 Paris, France; Inserm, U 1127, Paris, France; CNRS, UMR 7225, Paris, France. · CEA UNATI, Neurospin, CEA Gif-sur-Yvette, France & CATI multicenter neuroimaging platform. · Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. · Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Psychosomatic Medicine, University of Rostock, and DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany. · Department of Nuclear Medicine, University Hospital of Cologne, Cologne Germany. · Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland. · Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France. · Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpétrière University Hospital, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France. · Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, UK. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Inserm U1127 Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière Paris, France. · Inserm UMR1027, University of Toulouse, Toulouse, France. · Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Pubmed 26478889
5 Other Locations Show
Yearly article counts 01112111010
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.